Home・Список акций・Penumbra Inc

Penumbra Inc

Закрыт

СекторЗдравоохранение

316.87 -0.53

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

316.87

Макс.

317.89

Ключевые показатели
By Trading Economics
Доход	2.2M 35M
Продажи	15M 390M
P/E Средняя по отрасли	78.783 56.432
Прибыль на акцию	0.88
Рентабельность продаж	8.925
Сотрудники	4,700
EBITDA	5.5M 52M

Рекомендации
By TipRanks
Рекомендации	Нейтрально
Прогноз на 12 месяцев	+12.85% upside

Дивиденды
By Acuity
Следующий отчет о доходах	4 нояб. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	33M 13B
Предыдущая цена открытия	317.4
Предыдущая цена закрытия	316.87

Новостные настроения

By Acuity

50%

115 / 339 Рейтинг в Healthcare

Penumbra Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

17 сент. 2026 г., 19:46 UTC

Penumbra Inc is trading slightly lower, remaining roughly flat since Wednesday's close and positioned near the lower end of its one-month range.

16 сент. 2026 г., 22:06 UTC

Penumbra Inc declined in after-market trading, closing lower than Wednesday's close and remaining below the 20-day moving average amid broader market weakness.

28 авг. 2026 г., 19:36 UTC

Penumbra Inc shares are advancing during Friday's session. The stock's performance aligns with ongoing inflation concerns highlighted by recent Fed comments.

27 авг. 2026 г., 21:01 UTC

Penumbra Inc shares are higher in after-market trading. No specific news was identified to explain this movement, though broader market sentiment remains steady.

26 авг. 2026 г., 20:08 UTC

Penumbra Inc's shares are lower today, impacted by a notable decline in the Health Care Equipment sub-sector. No specific news has been identified.

25 авг. 2026 г., 23:01 UTC

Penumbra Inc shares are higher in after-market trading, recovering from earlier declines amid broader market resilience despite fluctuations linked to falling crude oil prices.

24 авг. 2026 г., 23:11 UTC

Penumbra Inc shares are higher in after-market hours, reflecting notable gains since Monday's close and reaching a session high within its one-month trading range.

22 авг. 2026 г., 00:02 UTC

Penumbra Inc shares are higher in after-market hours, rebounding alongside major stocks and remaining above the 20-day moving average. No specific news was identified.

21 авг. 2026 г., 23:31 UTC

Penumbra Inc's shares are higher in after-market trading, rebounding from an initial decline. The stock is above its 20-day moving average.

17 авг. 2026 г., 19:36 UTC

Correlated Moves

Penumbra Inc. shares are lower today, reflecting broader market declines amid rising bond yields and geopolitical tensions. The stock is near its one-month range high.

10 авг. 2026 г., 19:36 UTC

Correlated Moves

Penumbra Inc shares are higher today, supported by positive trends in the health care equipment sector and the performance of related ETFs.

8 авг. 2026 г., 00:02 UTC

Penumbra Inc shares are trading higher in after-market hours, maintaining strength above the 20-day moving average and near the upper end of their one-month range.

7 авг. 2026 г., 19:56 UTC

Penumbra Inc. shares are lower today, despite earlier gains, amid a broader market influenced by a disappointing jobs report and shifting monetary policy sentiment.

6 авг. 2026 г., 19:36 UTC

Penumbra Inc shares are modestly higher today, maintaining an upward trajectory. No specific company news was identified to explain the price movement.

5 авг. 2026 г., 21:03 UTC

Penumbra Inc shares are higher in after-market hours, though no specific news explains the movement. The stock remains above its 20-day moving average.

4 авг. 2026 г., 19:36 UTC

Penumbra Inc shares are higher today, reflecting a slight gain since Monday. The stock remains above its 20-day moving average amid broader market trends.

3 авг. 2026 г., 21:01 UTC

Penumbra Inc. shares are lower in after-market trading, despite gains in the broader market. The decline began shortly after Monday's close.

24 июл. 2026 г., 16:36 UTC

Correlated Moves

Penumbra Inc's shares are higher today, supported by gains in the medical devices sector and a decline in oil prices easing inflation concerns.

Сравнение c конкурентами

Изменение цены

Penumbra Inc Прогноз

Целевая цена

By TipRanks

12.85% рост

Прогноз на 12 месяцев

Средняя 358.4 USD 12.85%

Максимум 374 USD

Минимум 320 USD

Основано на мнении 6 аналитиков Wall Street, спрогнозировавших целевые цены для Penumbra Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

6 ratings

Покупка

Удержание

Продажа

Основано на мнении 6 аналитиков, присваивавших рейтинги акциям Penumbra Inc – Данные за последние 3 месяца.

Настроения

By Acuity

115 / 339Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.